LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company’s 5.750 percent senior notes, due 2028 (the “2028 notes”), at 99.705 percent of the principal amount and $750 … [Read more…]
SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022, at 12:35 p.m. ET/9:35 a.m. PT. A live webcast of … [Read more…]
Second of three approved U.S. oncology biosimilars Amneal expects to launch BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the commercial launch of RELEUKO® (filgrastim-ayow), a biosimilar referencing Neupogen®. RELEUKO® is used to treat neutropenia which is commonly experienced by patients undergoing chemotherapy. This product was developed in collaboration with … [Read more…]
LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022. … [Read more…]
BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 4:30 p.m. ET at the Lotte New York Palace. A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. … [Read more…]
– Event to highlight recurrent CDI market opportunity and SER-109 launch preparations – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will host an investor webcast to discuss the planned commercialization approach and market opportunity for therapeutic candidate SER-109 in recurrent C. difficile infection (rCDI) on Thursday, … [Read more…]
– TAK-003 is Being Evaluated for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals 4 Years Through 60 Years of Age OSAKA, Japan and CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of the Biologics License Application (BLA) … [Read more…]
Mika will help guide PhenoVista’s leadership in the company’s new phase of growth. SAN DIEGO–(BUSINESS WIRE)–PhenoVista Biosciences, a leading provider of advanced phenotypic discovery services, announced today that Justin Mika has joined their Board of Advisors. Mr. Mika has helped lead growth-oriented biotechnology and contract research organizations for over 15 years. At PhenoVista, Mr. Mika … [Read more…]
New resources made available during Native American Heritage Month to improve health outcomes for American Indian and Alaska Native youth OKLAHOMA CITY–(BUSINESS WIRE)–The Association of American Indian Physicians (AAIP), a national non-profit working to improve the health of American Indian and Alaska Native communities, is partnering with the Centers for Disease Control (CDC) in a … [Read more…]
Art by St. Jude Children’s Research Hospital patient Bridget inspires sculpture on Carnival’s newest ship, Carnival Celebration MEMPHIS, Tenn.–(BUSINESS WIRE)–Carnival Cruise Line unveiled its newest ship, Carnival Celebration on Sunday, Nov. 20 in Miami. While fish are usually found in the sea, one special fish has pride of place onboard the gleaming new vessel: a … [Read more…]
